Skip to main content
رجوع
Watch Compare

Orthofix Medical Inc.

جودة البيانات: 100%
OFIX
Nasdaq Manufacturing Measuring & Analyzing Instruments
KWD 12.49
▲ KWD 0.29 (2.38%)
القيمة السوقية: 501.40 M
السعر
KWD 12.49
القيمة السوقية
501.40 M
نطاق اليوم
KWD 12.09 — KWD 12.65
نطاق 52 أسبوعًا
KWD 10.24 — KWD 16.99
حجم التداول
131,313
فتح KWD 12.42
متوسط 50 يوم / 200 يوم
KWD 12.65
1.30% below
متوسط 50 يوم / 200 يوم
KWD 13.72
8.97% below

Quick Summary

النقاط الرئيسية

Revenue grew 15.35% annually over 5 years — strong growth
Debt/Equity of 0.36 — conservative balance sheet
Generating 33.35 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 12.50%

النمو

Revenue Growth (5Y)
15.35%
أعلى من متوسط القطاع (9.35%)
Revenue (1Y)2.85%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-20.47%
أعلى من متوسط القطاع (-51.02%)
ROIC-9.45%
Net Margin-11.21%
Op. Margin-9.90%

الأمان

Debt / Equity
0.36
أعلى من متوسط القطاع (0.33)
Current Ratio2.47
Interest Coverage-4.66

التقييم

PE (TTM)
-5.44
أقل من متوسط القطاع (-1.98)
P/B Ratio1.13
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (44 نظير)
المقياس السهم وسيط القطاع
P/E -5.4 -2.0
P/B 1.1 5.1
ROE % -20.5 -51.0
Net Margin % -11.2 -150.2
Rev Growth 5Y % 15.4 9.3
D/E 0.4 0.3

ETFs Holding This Stock

LFSC logo LFSC F/M Emerald Life Sciences Innovation ETF
0.83% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0.08% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.05% weight
AVUS logo AVUS Avantis U.S. Equity ETF
0.00% weight
IWV logo IWV iShares Russell 3000 ETF
0.00% weight
EBI logo EBI Longview Advantage ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 2.85% Revenue Growth (3Y) 4.95%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 15.35% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 822.31 M Net Income (TTM) -92.19 M
ROE -20.47% ROA -11.04%
Gross Margin 68.83% Operating Margin -9.90%
Net Margin -11.21% Free Cash Flow (TTM) 33.35 M
ROIC -9.45% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.36 Current Ratio 2.47
Interest Coverage -4.66 Asset Turnover 0.98
Working Capital 234.32 M Tangible Book Value 171.91 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -5.44 Forward P/E N/A
P/B Ratio 1.13 P/S Ratio 0.61
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 6.65%
Market Cap 501.40 M Enterprise Value 595.76 M
Per Share
EPS (Diluted TTM) -2.33 Revenue / Share 20.48
FCF / Share 0.83 OCF / Share 0.83
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion -36.17%
SBC-Adj. FCF 5.34 M Growth Momentum -12.50

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 822.31 M 799.49 M 746.64 M 460.71 M 464.48 M
Net Income -92.19 M -126.00 M -151.40 M -19.75 M -38.38 M
EPS (Diluted) -2.33 -3.30 -4.12 -0.98 -1.95
Gross Profit 566.02 M 545.89 M 486.27 M 337.17 M 349.57 M
Operating Income -81.43 M -84.62 M -139.11 M -13.27 M -8.32 M
EBITDA — — — — —
R&D Expenses 65.85 M 73.64 M 80.23 M 49.07 M 49.62 M
SG&A Expenses 554.33 M 532.53 M — — —
D&A 77.32 M 60.06 M 53.06 M 29.02 M 29.60 M
Interest Expense -17.49 M -29.63 M -8.63 M -1.29 M -1.84 M
Income Tax 1.38 M 2.12 M 2.72 M 2.04 M 24.88 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 850.65 M 893.29 M 925.32 M 458.63 M 476.62 M
Total Liabilities 400.61 M 390.17 M 326.59 M 121.77 M 139.69 M
Shareholders' Equity 450.04 M 503.12 M 598.73 M 336.86 M 336.93 M
Total Debt 157.39 M 157.02 M 94.36 M — —
Cash & Equivalents 82.03 M 83.24 M 33.11 M 50.70 M 87.85 M
Current Assets 416.85 M 433.29 M 420.44 M 255.99 M 269.52 M
Current Liabilities 170.48 M 168.63 M 165.22 M 83.62 M 105.83 M